Miami Cancer Institute Global Summit on Immunotherapies for Hematologic Malignancies, Sixth Annual

March 7, 2025 to March 8, 2025
 

Live Symposium
Friday-Saturday, March 7-8, 2025
JW Marriott Miami, Miami, FL

Given the increasing frequency of hematologic malignancies and the complexities of treatments with novel agents, particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore have become more complex.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

  • Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
  • Provide an update of new molecular and immunological treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
  • Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.

Who Should Attend

This symposium is directed toward hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, oncology, hematology nurses, laboratory personnel, pharmacists and other allied health care team members interested in the treatment of patients with hematologic malignancies.

Registration and Fees

 Before February 3, 2025After February 3, 2025
Physicians*$338$375
Advanced Practice Providers$175$195
Physicians-in-Training**$121$135
Baptist Health Employees$99$110
Others$203$225

* 20% Group discounts available for three or more providers who register together as a group by Monday, February 3, 2025. No add-ons. Call for details.

** Registration must be accompanied by a letter from the Fellowship/Residency Director.

Event date: Friday-Saturday, March 7-8, 2025

Cancellation Policy

Cancellations must be received by Friday, February 21, 2025 to receive a refund of the registration fee, less a $35 administrative fee. Registration fees are not refundable after Friday, February 21, 2025.

Course Summary
Course opens: 
07/01/2024
Course expires: 
03/31/2025
Event starts: 
03/07/2025 - 8:00am EST
Event ends: 
03/08/2025 - 1:15pm EST
Cost:
$1.00

Agenda

Friday, March 7

7:30 - 8:15 a.m.Registration and Continental Breakfast
7:30 - 8:15 a.m.Product Theater 
8:40 - 9:00 a.m. Welcome and Introductions
Guenther Koehne, M.D., Ph.D. 
Multiple Myeloma
9:00 - 9:25 a.m.From Doublets to Quadruple Combination Therapies for Newly Diagnosed Multiple Myeloma and Beyond: The Transformative Effect of Induction/Remission Therapy Followed by Maintenance in the Era of Novel Therapies
Paul Richardson, M.D.
9:25 - 9:50 a.m.Update on T-cell Redirecting Therapies for Relapsed/Refractory Multiple Myeloma
Adam Cohen, M.D.
9:50 - 10:15 a.m. Landscape of Multiple Myeloma Therapies in LATAM: Current Status and Unmet Needs
Patricio Duarte, M.D.
10:15 - 10:35 a.m.Panel Discussion
10:35 - 11:00 a.m.Break and Exhibits
Non-Hodgkin Lymphoma
11:00 - 11:25 a.m.Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL): Where Are We and Where Are We Heading?
Matthew Matasar, M.D.
11:25 - 11:50 a.m. Positioning Transplantation and Cellular Therapies in the ‘Other’ B-NHLs (FL, MCL, CLL/SLL)
Craig Sauter, M.D.
11:50 - 12:25 p.m.Reporting Outcome to a CAR T-cell Registry?
Marcelo Pasquini, M.D.
12:25 - 12:45 p.m.Panel Discussion
12:45 - 1:15 p.m.Lunch and Exhibits 
1:15 - 1:45 p.m.Product Theater 
Special Presentations
1:45 - 2:15 p.m. Next Steps in CAR T-cell Therapies
Michel Sadelain, M.D., Ph.D.
2:15 - 2:45 p.m.    Strategies to Enhance Enrollment of Under-served Patients Onto Bone Marrow Transplant and Cellular Therapy Clinical Trials
Juliet Barker, MBBS (Hons), FRACP
2:45 - 3:05 p.m. Break and Exhibits
Acute Myeloid Leukemia
3:05 - 3:30 p.m. AML 2025: Therapeutic Integration of New Agents
Richard Stone, M.D.
3:30 - 3:55 p.m.Targeted Therapies in Acute Myeloid Leukemia
Eytan Stein, M.D.
3:55 - 4:20 p.m.Myelofibrosis: Current and Emerging Treatments
Raajit Rampal, M.D.
4:20 - 4:40 p.m.Panel Discussion
4:45 - 5:30 p.m.Product Theater 
5:30 p.m. Adjourn

Saturday, March 8

7:30 – 8:00 a.m. Product Theater 
8:00 – 8:30 a.m. Registration and Breakfast 
Novel Approaches to AML Therapies
8:30 – 9:00 a.m. Antigen Specific T-cell Therapies - From Targeting Viruses to AML
Catherine Bollard, M.D.
9:00 – 9:20 a.m.LYT-200, an Anti-Galectin-9 Antibody, for Treatment of AML/high-risk MDS
Aleksandra Filipovic M.D. Ph.D.
9:25 – 9:45 a.m.Novel Approaches to Treat AML Relapse Post Allo SCT
Guenther Koehne, M.D., Ph.D.
9:45 – 10:00 a.m.   Panel Discussion
10:00 – 10:15 a.m.Break and Visit Exhibits
10:15 – 11:00 a.m. Product Theater 
Allogeneic Stem Cell Transplants
11:00 – 11:30 a.m.Next Steps in Cancer Immunotherapy
Marcel van den Brink, M.D., Ph.D.
11:30 – 12 noon Uncoupling GVL and GVH - Déjà Vu All Over Again?
Robert Soiffer, M.D.
12 – 12:30 p.m.The Role of Haploidentical Transplants in 2025
Leo Luznik, M.D.
12:30 – 12:55 p.m. Novel Approaches to GVHD Prevention and Therapy
Corey Cutler, M.D. 
12:55 – 1:15 p.m.      Panel Discussion
1:15 p.m. Adjourn

NOTE: Schedule subject to change.

JW Marriott Miami
Miami, FL
United States

image

JW Marriott Miami

1109 Brickell Avenue
Miami, Florida 33131
United States
+1 (305) 329-3500


About the Venue

The JW Marriott Miami is located in the heart of Brickell, Miami's trendy destination for dining, shopping, and nightlife and is located a short walk away from the popular shopping and entertainment destination, Brickell City Centre. Guests are not far from all that Miami has to offer including the Perez Art Museum, Frost Science Museum, Kaseya Center (home of the Miami Heat), Adrienne Arsht Center, Port of Miami, South Beach, Coral Gables, Coconut Grove and Miami International Airport.

Rooms Rates and Highlights

  • Special group rates starting from $389 USD per night, plus taxes/fees
  • 24-hour room service - Free Wi-Fi for Marriott Bonvoy members - Complimentary fitness center access - Spa - Pool - Business Center

Travel Information

The drive time between the JW Marriott Miami and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 8.2 miles.

Services + Amenities

Relax with a facial or full body massage by an expert therapist at Salus Spa. Afterward, continue to unwind in the warmth of the Miami sun at the JW Marriott Miami's stainless steel sky pool.

Adjacent to The Spa is our Fitness Studio, the perfect escape for an energizing workout, featuring state-of-art equipment and free weights.

Dining

Isabela's
With its natural light and views of Brickell Ave, Isabela's is the perfect place to start the day.

La Terraza Cafe & Bar
With its Plasma TV's and LED Screens tuned to popular sporting events & delicious casual fare served at lunch, dinner, and weekend Brunch makes La Terraza the ideal place to unwind with friends and family.


Downtown Miami and Brickell

Greater Miami is synonymous with beautiful beaches and towering palm trees - but in its urban center, it is the cityscape of glittering skyscrapers over Biscayne Bay that gets all the attention. Diverse, dynamic and densely populated, Downtown Miami and the adjoining Brickell area is a hub of international finance, dining, arts and entertainment that no visitor should miss.

Explore Downtown Miami and BrickellExplore Miami

COVID-19 Protocols for All Attendees, Exhibitors and Vendors

Proof of COVID-19 vaccination or negative COVID-19 test is no longer required to attend a Baptist Health CME conference or symposium.

Baptist Health's in-person COVID-19 policy is subject to change based on COVID-19 community levels and any updated guidance from CDC and/or federal or state officials in localities hosting a Baptist Health in-person meeting or event. Baptist Health reserves the right to modify its COVID-19 related procedures and health screening protocols in its sole discretion at any time. Participants will be informed of any such changes on an ongoing basis.

Masks are welcome but not required. Please understand and respect that wearing a mask is a personal and individual choice of your fellow conference attendees.  Masks will made available for attendees onsite at conferences upon request.

Symposium Director

image
Guenther Koehne, M.D., Ph.D.
Deputy Director
Chief, Blood and Marrow Transplant and Hematologic Oncology
Miami Cancer Institute
Miami, Florida

Faculty

image
Juliet Barker, M.B.
Hematology/Oncology
Bone Marrow Transplant and Cellular Therapy Program
Weill Cornell Medicine
New York, New York
image
Catherine Bollard, M.D.
Director, Center for Cancer and Immunology
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Interim Chair, Department of Pediatrics
Interim Director, Children's National Research Institute
Interim Executive Vice President & Chief Academic Officer
Children's National Hospital
Washington, D.C.
image
Adam Cohen, M.D.
Associate Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
image
Corey Cutler, M.D.
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
image
Patricio Duarte, M.D.
Associate Professor of Hematology
Instituto Universitario CEMIC
Bueno Aires, Argentina
image
Aleksandra Filipovic, M.D., Ph.D.
Department of Surgery and Cancer
Imperial College of London
London, England
image
Leo Luznik, M.D.
Professor of Oncology
Johns Hopkins Medicine
Baltimore, Maryland
image
Matthew J. Matasar, M.D.
Chief, Division of Blood Disorders
Rutgers CINJ and RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
image
Marcelo Pasquini, M.D.
Medical Oncologist
Medical College of Wisconsin
Milwaukee, Wisconsin
image
Raajit K. Rampal, M.D., Ph.D.
Associate Member
Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York
image
Paul G. Richardson, M.D.
Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
image
Michel Sadelain, M.D., Ph.D.
Director
Center for Cell Engineering
Memorial Sloan Kettering Cancer Center
New York, New York
image
Craig Sauter, M.D.
Hematology and Medical Oncology
Director, Blood and Marrow Transplant Program
Cleveland Clinic Main Campus
Cleveland, Ohio
image
Robert Soiffer, M.D.
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
image
Eytan Stein, M.D.
Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
image
Richard Stone M.D.
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
image
Marcel R.M. van den Brink, M.D., Ph.D. 
Medical Oncologist
Head, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

NOTE: Faculty subject to change.

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Credits Pending

Price

Cost:
$1.00
Please login or register for a Baptist Health CME account to take this course.